Metastatic urothelial (bladder, ureter/renal pelvis) cancer samples of 103 patients were analyzed in an investigation to find out whether fibroblast growth factor receptor 3 (FGFR3)-altered phenotype correlates with altered response to ICIs. Here, FGFR3 is linked to cancer.